| Literature DB >> 29125577 |
Yang-Mei Zhang1, Bai-Lian Liu2, Xin-Heng Zheng3, Xiao-Jun Huang4, Hong-Yu Li5, Ying Zhang6, Ting-Ting Zhang7, Da-Yuan Sun8, Bi-Run Lin9, Guang-Xiong Zhou10.
Abstract
Anandins A (1) and B (2), two rare steroidal alkaloids, were isolated from the fermentative broth of a marine actinobacteria Streptomyces anandii H41-59. The gross structures of the two alkaloids were elucidated by spectroscopic methods including HR-ESI-MS, and NMR. Their absolute configurations were confirmed by single-crystal X-ray diffraction analysis and comparison of their experimental and calculated electronic circular dichroism spectra, respectively. Anandin A exhibited a moderate inhibitory effect against three human cancer cell lines MCF-7, SF-268, and NCI-H460 with IC50 values of 7.5, 7.9, 7.8 μg/mL, respectively.Entities:
Keywords: Streptomyces anandii; anandins A and B; cytotoxicity; steroidal alkaloids
Mesh:
Substances:
Year: 2017 PMID: 29125577 PMCID: PMC5706044 DOI: 10.3390/md15110355
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Chemical structure of anandins A (1) and B (2).
1H and 13C NMR data of 1 and 2 (δ in ppm, J in Hz).
| Position | 1 a | 2 b | ||
|---|---|---|---|---|
| 2 | - | 171.1 | - | 171.1 |
| 3 | 5.63 (br.s) | 115.3 | 5.52 (d, 1.9) | 116.5 |
| 4 | - | 152.0 | - | 164.9 |
| 5 | - | 141.5 | - | 89.3 |
| 6 | 5.60 (m) | 107.4 | 1.65 (m), 1.92 (m) | 36.0 |
| 7 | 2.63 (m), 2.34 (dd, 2.5, 17.5) | 40.8 | 2.23 (m), 1.60 (m) | 35.7 |
| 8 | - | 47.0 | - | 49.1 |
| 9 | 2.68 (m) | 49.4 | 2.65 (m) | 50.1 |
| 10 | 1.48 (m), 1.93 (m) | 29.7 | 1.46 (m), 1.91 (m) | 29.6 |
| 11 | 1.51 (m), 1.94 (m) | 23.1 | 1.58 (m), 1.65 (m) | 22.0 |
| 12 | 1.59 (m) | 55.6 | 1.53 (m) | 56.3 |
| 13 | 0.71 (s) | 12.4 | 0.60 (s) | 12.1 |
| 14 | 2.13 (m) | 41.1 | 2.11 (br. s) | 41.2 |
| 15 | 1.08 (d, 6.9) | 21.5 | 1.08 (d, 6.9) | 21.5 |
| 16 | 5.27 (dd, 7.7, 15.1) | 136.4 | 5.28 (dd, 7.6, 14.6) | 136.4 |
| 17 | 5.30 (dd, 7.2, 15.1) | 133.1 | 5.30 (dd, 7.2, 14.6) | 133.1 |
| 18 | 1.90 (m) | 43.8 | 1.90 (m) | 43.8 |
| 19 | 1.51 (m) | 33.9 | 1.50 (m) | 33.9 |
| 20 | 0.84 (d, 6.9) | 20.1 | 0.85 (d, 6.9) | 20.1 |
| 21 | 0.87 (d, 6.9) | 20.4 | 0.88 (d, 6.9) | 20.4 |
| 22 | 0.95 (d, 6.8) | 18.2 | 0.96 (d, 6.9) | 18.2 |
| 1′ | 3.64 (m) | 42.8 | 3.32 (m), 3.60 (m) | 42.5 |
| 2′ | 3.63 (m) | 61.1 | 3.66 (m) | 62.3 |
| 5-OH | 5.12 (br.s) | - | ||
| 2′-OH | 3.87 (br.s) | - | 4.36 (br.s) | - |
a Measured in CD3COCD3 at 300 MHz for 1H and 75 MHz for 13C NMR; b Measured in CD3COCD3 at 600 MHz for 1H and 125 MHz for 13C NMR.
Figure 2Key 1H-1H COSY and HMBC correlations of 1.
Figure 3Key NOESY correlations and X-ray ORTEP of 1.
Figure 4Key 2D NMR correlations of 2.
Figure 5Key NOESY correlations of 2.
Figure 6Experimental and calculated ECD spectra of 2.
Cytotoxicities of 1 and 2 (IC50: μg/mL).
| Cell Line | 1 | 2 | |
|---|---|---|---|
| MCF-7 | 7.5 | >50 | 4.0 |
| SF-268 | 7.9 | >50 | 41.0 |
| NCI-H460 | 7.8 | >50 | 25.1 |
Concentration range: 1.56–100 μg/mL; IC50: half maximal inhibitory concentration.